In Pursuit of Precision: Clinical Relevance Makes All the Difference with CertisAI™ and Advanced Cancer Models

Time: 3:30 pm
day: Day One PM


  • Selecting an optimal artificial intelligence and machine learning platform for your drug discovery and development program: evaluation criteria to consider
  • Exploring new CertisAI differentiators: it’s the first and only commercially available drug response and synergy platform that can predict therapeutic efficacy — requiring just a small molecule as input
  • Reviewing new CertisAI in vivo validation study results using advanced orthotopic PDX models
  • Analyzing new immunology study results, comparing differential immune responses and tumor infiltration in sub-Q versus orthotopic implantation for successful translation of T cell-based therapies into the clinic